Home buttonDusty's place logo

Facebook IconFacebook Icon

Email Address:

Send me a newsletter
Take off list

Dusty's Place
P.O. Box 827
Shingle Springs, CA 95682
Tel: (530) 672-2473


Upcoming Event

Harvard University Expert to Host Scleroderma Webinar: New Directions for Scleroderma Treatments: Understanding the Basis for Current Clinical Trials on December 14, 2012
A Free Service Provided for Patients and Caregivers by the Scleroderma Research Foundation with support from Gilead Sciences, MedImmune and Novartis Where:

Register online at www.sclerodermaRESEARCH.org .

Research and Markets: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2012Published: December 3, 2012 

Global Markets Direct's, 'Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Sclerosis (Scleroderma).

To purchase or read more: http://www.heraldonline.com/2012/12/03/4455191/research-and-markets-systemic.html#storylink=cpy


American Society for Scleroderma Research
Dusty's Place Scleroderma Research Program
Hospital for Special Surgery - located in New York - Scleroderma Clinical Trials
Johns Hopkins Scleroderma Center – Scleroderma clinical trials
Low Dose Naltrexone and Autoimmune Diseases:
Emerging research about the benefits of a safe and inexpensive drug on autoimmune diseases
Scleroderma Clinical Trials Consortium
Scleroderma Research Foundation
The National Center for Complementary and Alternative Medicine - NCCAM conducts research on a wide variety of CAM approaches.


Privacy Statement
This website powered by Boost Logics, Inc. / © 2023 Boost Logics, Inc. & Dusty's Place